COVID-19 和心血管疾病
Kevin J Clerkin1, Justin A Fried1, Jayant Raikhelkar1
1Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York.
冠状病毒疾病2019 (COVID-19) 影响全球健康,严重急性呼吸系统冠状病毒2 (SARS-CoV-2) 影响心血管健康. 需要进一步研究心脏移植的治疗方法和挑战.
科学领域:
- 心脏病学
- 传染性疾病
- 病毒学
背景情况:
- 冠状病毒疾病2019 (COVID-19) 是由SARS-CoV-2引起的全球流行病.
- SARS-CoV-2利用血管激素转化酶2 (ACE2) 受体进入细胞.
- COVID-19 显著影响已有心血管疾病的患者,心肌损伤的患病率显著.
研究的目的:
- 调查ACE2在COVID-19发病过程中的作用.
- 探索ACE抑制剂 (ACEi) 和血管激素受体阻断剂 (ARB) 在COVID-19患者中的影响.
- 为应对COVID-19对心脏移植所带来的挑战.
主要方法:
- 审查有关COVID-19,SARS-CoV-2和心血管影响的当前文献.
- 对心肌损伤和ACE2受体参与的患者数据的分析.
- 讨论治疗策略和移植方案.
主要成果:
- 在COVID-19患者中患有心血管疾病和心肌损伤的高发病率.
- 已确定ACE2受体是SARS-CoV-2的主要入口点.
- 关于ACEi和ARB在COVID-19管理中的作用仍然存在不确定性.
- 在心脏移植中,COVID-19 复杂化了供体选择,免疫抑制和移植后护理.
结论:
- COVID-19对心血管健康构成重大风险,包括心肌损伤.
- 需要进一步研究ACE2在感染中的作用和相关药物的影响.
- 心脏移植方案需要适应COVID-19受影响的患者.
更多相关视频
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
相关概念视频
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
